Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Several studies have provided ample evidence of a clinically significant interobserver variation of the histological diagnosis of glioma. This interobserver variation has an effect on both the typing and grading of glial tumors. Since treatment decisions are based on histological diagnosis and grading, this affects patient care: erroneous classification and grading may result in both over- and undertreatment. In particular, the radiotherapy dosage and the use of chemotherapy are affected by tumor grade and lineage. It also affects the conduct and interpretation of clinical trials on glioma, in particular of studies into grade II and grade III gliomas. Although trials with central pathology review prior to inclusion will result in a more homogeneous patient population, the interpretation and external validity of such trials are still affected by this, and the question whether results of such trials can be generalized to patients diagnosed and treated elsewhere remains to be answered. Although molecular classification may help in typing and grading tumors, as of today this is still in its infancy and unlikely to completely replace histological classification. Routine pathology review in everyday clinical practice should be considered. More objective histological criteria for the grade and lineage of gliomas are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histologic diagnosis and grading of gliomas have been limited by considerable intra- and interobserver variability (42).”
From Predicting cancer outcomes from histology and genomics using convolutional networks (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the grading criteria in the current classification schema for oligodendrogliomas continues to predominantly rely upon histopathologic examination; the differentiating criterion between grade 2 and grade 3 oligodendrogliomas are the presence of conspicuous microvascular proliferation and/or 6 mitoses per 10 high-power field [3,4,5,6,7,8,9,10,11].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Importantly, these data further facilitate consensus ratings on radiology images (e.g., MRI) of expert radiologists to alleviate inconsistencies that often arise due to subjective impressions and inter- and intra-observer variability [229].”
From AI in Medical Imaging Informatics: Current Challenges and Future Directions (2020) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544 · cited 1×
“This issue is on the question of external validation or generalizability of the results of a trial, an often ignored element of clinical trials [26].”
BackgroundCairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,058
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O’Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.636 · Cited by 804
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Research works printed but not linked: 1
- Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381–1391 · doi:10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w
Cited by
Items 601–640 of 640
Gliomes diffus de bas grade : données épidémiologiques et hypothèses étiologiques.
Darlix, A. (2016) · theses.fr (ABES) · doi:10.70675/22f23acfza521z42cfza62az4304f7087af9
Mercier, M.-C. (2018) · theses.fr (ABES) · doi:10.70675/273bcce1z8572z472ez9afbzca3fd562301c
Ariey-Bonnet, J. (2020) · theses.fr (ABES) · doi:10.70675/63ceaea1ze673z40c3z9960zed4c40d88ea9
Leventoux, N. (2018) · theses.fr (ABES) · doi:10.70675/1b8ddd02z3a93z40cdz9da9z8c69201d9db7
Mouricout, E. D. (2018) · theses.fr (ABES) · doi:10.70675/acf19b58ze712z4fa5z832ezd636efae9c71
Étude pharmacologique du vorinostat dans le glioblastome
Perez, T. (2020) · theses.fr (ABES) · doi:10.70675/79b36641z00a1z4ac6zbd8dzff4f36df649b
Appay, R. (2022) · theses.fr (ABES) · doi:10.70675/e9a886d0zd18cz4119z93fcz7e6f851b55ac
Caractérisation multi-omique des tumeurs gliales et glioneuronales avec altération des gènes FGFR1-3
Métais, A. (2024) · theses.fr (ABES) · doi:10.70675/2af8f09dz1749z4403z8883z657a86818d97
Variational methods for large-scale data problems in imaging
Martin, S. (2024) · theses.fr (ABES) · doi:10.70675/5e40bd9ez7e47z4669za810zcfc2fff98d69
A rare case of atypical teratoid rhabdoid tumor with extracranial extension in a child
Quadri, N., Park, M., Heredia, V., & Kemp, J. (2026) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2026.102262
Fonseca, A., Yefet, L. S., Singh, O., Dampier, C. H., Dazelle, K., Lam, M., Abdullaev, Z., Chung, H., Quezado, M., Raffeld, M. A., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag082
Anbunesan, S. N., Hassan, M. A., Qi, J., Kraft, L., Lee, H. S., Bloch, O., & Marcu, L. (2026) · arXiv (Cornell University) · doi:10.48550/arxiv.2604.26147
Zakavi, S. A., Radnia, P., Karizno, M. A., Tafazolimoghadam, A., Amiri, H., Deravi, N., & Fathi, M. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-08767-y
Multi-threshold volumetric 18F-FET PET for tumor detection and prognosis in primary glioma
Oo, T. T., Grega, S. D., Smith, N. J., Deaton, T. K., Ciantar, K. G., Territo, W. L., Mao, L., Sidenbender, S., Ocaña, J. A., Larson, M., et al. (2026) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdag159
Särestöniemi, M., Singh, D., Jarva, E., & Reponen, J. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-28819-6
Multiparametric MRI Analysis in Glioma Grading: Added Value of ADC Maps
Ibrahim, N., Panfilov, E., Salokorpi, N., & Keinänen, T. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-28819-6_19
Nisnboym, M., Bartman, K., Price, M., Benedetti, J. R., Landi, D. B., Peters, K. B., Brat, D. J., Tihan, T., Kruchko, C., Barnholtz‐Sloan, J. S., et al. (2026) · Neuro-Oncology Practice · doi:10.1093/nop/npag064
Mercado-Hernández, J., Martín-Calvo, D., Carniglia, G., Díaz‐Morales, N., Düwel, A., Fuentes-Calvo, I., Collado, L. G., Kovalchuk, A., López-Hernández, F. J., Martín-Fernández, N., et al. (2026) · BioMedInformatics · doi:10.3390/biomedinformatics6050084
Lopes, O. M. S., Oliveira, J. A., Nogueira, V. B. A., Ribeiro, L. F., Zamae, M. I. S., Vieira, M. F. G. O., Pimenta, V. M. D. E., & Reis, Z. S. N. (2026) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-026-06519-4
ARTIFICIAL INTELLIGENCE-BASED COMPUTATIONAL PATHOLOGY (AI-CPath) PLATFORM FOR LUNG CANCER
Chegedekova, I. (2025) · Nazarbayev University Repository (Nazarbayev University)
Su, Y., Li, F., Yang, H., Bai, J., & Lu, J. (2026) · Diagnostic Pathology · doi:10.1186/s13000-026-01836-1
Xiang, X., Huang, D., Zhang, H., Guo, L., Ma, X., Ying, L., Xu, J., & Shao, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-70119-y
Diksin, M. A. M. (2021) · Nottingham ePrints (University of Nottingham)
Guo, X., Sun, P., Zhang, X., Lu, J., Qin, Q., Chen, J., Hao, X., Wu, J., & Wang, J. (2026) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70615
Kuijsters, M. C., Bolt, T. C., Maas, S. L. N., & Koppes, S. A. (2026) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqag124
Yang, G., Shan, D., Zhao, R., & Li, G. (2022) · doi:10.3389/fcell.2022.902298.s004
Munquad, S., Si, T., Mallik, S., Das, A. B., & Zhao, Z. (2022) · doi:10.3389/fgene.2022.855420.s009
Li, Y., Xu, S., Xu, D., Pan, T., Guo, J., Gu, S., Lin, Q., Li, X., Li, K., & Xiang, W. (2022) · doi:10.3389/fimmu.2022.853904.s006
Metadata
- Authors
- van den Bent, M. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-07-20
- Volume
- 120
- Issue
- 3
- Pages
- 297-304
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2910894
- OpenAlex
- W2112567075
- Cited by
- 577
- References
- 35
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 70 · 2023: 43 · 2022: 43 · 2021: 47 · 2020: 48 · 2019: 52 · 2018: 33 · 2017: 46 · 2016: 44 · 2015: 33 · 2014: 16 · 2013: 16 · 2012: 20
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- glioma, interobserver variability, histopathological diagnosis, tumor grading, tumor classification, central pathology review, clinical trial interpretation, generalizability, molecular classification, chemotherapy
- MeSH terms
- Brain Neoplasms, Clinical Trials as Topic, Glioma, Humans, Observer Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.